e-Clinical Solutions Market (By Product: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM) , Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF); By Delivery Mode: Web-hosted, Licensed Enterprise, Cloud-based; By Development Phase: Phase I, Phase II, Phase III, Phase IV; By End-use: Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021-2030

The global e-clinical solutions market size is expected to be worth around US$ 22.7 billion by 2030, according to a new report by Vision Research Reports.

The global e-clinical solutions market size was valued at US$ 7.9 billion in 2020 and is anticipated to grow at a CAGR of 13.7% during forecast period 2021 to 2030.

Report Coverage

Report Scope Details
Market Size USD 22.7 Billion by 2030
Growth Rate CAGR of 13.7% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, delivery mode, development phase, end-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Datatrak International, Inc.; Oracle; Parexel International Corporation; Dassault Systemes; Bioclinica; Datatrak International, Inc.; CRF Health; ERT Clinical; eClinicalWorks; IBM; Anju Life Sciences Software; eClinical Solutions

Growth Factors

Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage a huge influx of specimens on a daily basis.

Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to drive the market for eClinical solutions. 

By Product Analysis

The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of 20.9% in 2020. eCOA is estimated to be the fastest-growing segment during the forecast period owing to the rising significance of high-quality clinical data.

Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. These aforementioned benefits are expected to fuel its demand in the coming years. 

By Delivery Mode Analysis

The web-hosted segment dominated the market for eClinical solutions and accounted for the largest revenue share of around 75.2% in 2020. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required.

The cloud-based segment is anticipated to exhibit an exponential CAGR of 14.3% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. 

By Development Phase Analysis

On the basis of the development phase, the phase III segment dominated the market for eClinical solutions and accounted for the largest revenue share of 52.9% in 2020. The spiraling need for the incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.

The phase I segment is estimated to be the most promising segment during the forecast period owing to the high significance of these systems to predict future outcomes and eliminate drug candidates possessing the least probability of success. 

By End-use Analysis

 The CROs segment dominated the market for eClinical solutions and held the largest revenue share of 37.8% in 2020. The segment is projected to rise at a remarkable CAGR during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure. 

Benefits involved in outsourcing clinical trials to CROs are responsible for the heightened growth of this segment. These benefits include cost advantages, increased efficiency of services, enhanced productivity, and a higher focus on core areas of development critical to a company’s growth.

By Regional Analysis

North America dominated the eClinical solutions market and accounted for the largest revenue share of 53.1% in 2020. The increasing target population, coupled with the rising prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders, is poised to stimulate the growth of the market. 

In Asia Pacific, the market for eClinical solutions is likely to register a noteworthy CAGR at 15.5% over the forecast period. High unmet medical needs and the rising prevalence of target chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are stoking the demand for software solutions in the region

Key Players 

  • Datatrak International, Inc.

  • Oracle

  • Parexel International Corporation

  • Dassault Systemes

  • Bioclinica

  • Datatrak International, Inc.

  • CRF Health

  • ERT Clinical

  • eClinicalWorks

  • IBM

  • Anju Life Sciences Software

  • eClinical Solutions

Market Segmentation

  • By Product

    • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 

    • Clinical Trial Management Systems (CTMS)

    • Clinical Analytics Platforms

    • Randomization and Trial Supply Management (RTSM) 

    • Clinical Data Integration Platforms

    • Electronic Clinical Outcome Assessment (eCOA)

    • Safety Solutions

    • Electronic Trial Master File (eTMF)

  • By Delivery Mode

    • Web-hosted (On demand)

    • Licensed Enterprise (On premise)

    • Cloud-based

  • By Development Phase

    • Phase I

    • Phase II

    • Phase III

    • Phase IV

  • By End-use

    • Hospitals/Healthcare providers

    • CROs

    • Academic Institutes

    • Pharma & Biotech Organizations

    • Medical Device Manufacturers

  • Regional

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Netherlands

      • Sweden

      • Denmark

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Australia

      • New Zealand

      • Taiwan

      • Hong Kong

      • Singapore

      • Thailand

      • Vietnam

    • Central & South America

      • Brazil

      • Argentina

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Egypt

      • Qatar

The EClinical Solutions market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of EClinical Solutions market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global EClinical Solutions market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the EClinical Solutions market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted EClinical Solutions market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the EClinical Solutions capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of EClinical Solutions by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global EClinical Solutions market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major EClinical Solutions market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of EClinical Solutions market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the EClinical Solutions industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

EClinical Solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to EClinical Solutions market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of EClinical Solutions market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new EClinical Solutions market. These factors have benefited the growth of the global market for EClinical Solutions. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for EClinical Solutions. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of EClinical Solutions are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Development Phase Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global E-Clinical Solutions Market, By Product

7.1.  E-Clinical Solutions Market, by Product, 2021-2030

7.1.1.    Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Clinical Trial Management Systems (CTMS)

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Clinical Analytics Platforms

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Randomization and Trial Supply Management (RTSM)

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Clinical Data Integration Platforms

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Electronic Clinical Outcome Assessment (eCOA)S)

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Safety Solutions

7.1.7.1.        Market Revenue and Forecast (2017-2030)

7.1.8.    Electronic Trial Master File (eTMF)

7.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global E-Clinical Solutions Market, By Delivery Mode

8.1.  E-Clinical Solutions Market, by Delivery Mode, 2021-2030

8.1.1.    Web-hosted (On demand)

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Licensed Enterprise (On premise)

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Cloud-based

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global E-Clinical Solutions Market, By Development Phase

9.1.  E-Clinical Solutions Market, by Development Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global E-Clinical Solutions Market, By End-user

10.1.        E-Clinical Solutions Market, by End-user, 2021-2030

10.1.1.  Hospitals/Healthcare providers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  CROs

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Academic Institutes

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Pharma & Biotech Organizations

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Medical Device Manufacturers

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global E-Clinical Solutions Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12.  Company Profiles

12.1.              Datatrak International, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Oracle

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Parexel International Corporation

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Dassault Systemes

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bioclinica

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Datatrak International, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              CRF Health

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              ERT Clinical

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              eClinicalWorks

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           IBM

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers